Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England.
Janet E BrownBrooke HarrowAnne MarciniakChristine McCarthyAude HouchardLori CirneanuAndrew ProtheroePublished in: Drugs - real world outcomes (2024)
ClinicalTrials.gov, NCT04637204; registered November 2020.